Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a)

被引:44
|
作者
Krychtiuk, Konstantin A. [1 ,2 ]
Kastl, Stefan P. [1 ]
Hofbauer, Sebastian L. [1 ]
Wonnerth, Anna [1 ]
Goliasch, Georg [1 ]
Ozsvar-Kozma, Maria [3 ]
Katsaros, Katharina M. [1 ]
Maurer, Gerald [1 ]
Huber, Kurt [2 ,4 ]
Dostal, Elisabeth [5 ]
Binder, Christoph J. [3 ]
Pfaffenberger, Stefan [1 ]
Oravec, Stanislav [5 ,6 ]
Wojta, Johann [1 ,2 ,7 ]
Speidl, Walter S. [1 ]
机构
[1] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, A-1090 Vienna, Austria
[2] Ludwig Boltzmann Cluster Cardiovasc Res, Vienna, Austria
[3] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria
[4] Wilhelminenhosp, Dept Med 3, Vienna, Austria
[5] Krankenanstalten Dr Dostal, Vienna, Austria
[6] Comenius Univ, Fac Med, Dept Internal Med 2, Bratislava, Slovakia
[7] Med Univ Vienna, Core Facil, A-1090 Vienna, Austria
基金
奥地利科学基金会;
关键词
Lipoprotein(a); Atherosclerosis; Coronary artery disease; Monocyte subsets; Oxidized phospholipids; CORONARY-ARTERY-DISEASE; HIGH-DENSITY-LIPOPROTEIN; LP(A) LIPOPROTEIN; CARDIOVASCULAR-DISEASE; OXIDIZED PHOSPHOLIPIDS; MYOCARDIAL-INFARCTION; PERIPHERAL-BLOOD; ANGINA-PECTORIS; HEART-DISEASE; INFLAMMATION;
D O I
10.1016/j.jacl.2015.04.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: Lipoprotein(a) (Lp(a)) is a proatherogenic plasma lipoprotein currently established as an independent risk factor for the development of atherosclerotic disease and as a predictor for acute thrombotic complications. In addition, Lp(a) is the major carrier of proinflammatory oxidized phospholipids (OxPL). Today, atherosclerosis is considered to be an inflammatory disease of the vessel wall in which monocytes and monocyte-derived macrophages are crucially involved. Circulating monocytes can be divided according to their surface expression pattern of CD14 and CD16 into at least 3 subsets with distinct inflammatory and atherogenic potential. OBJECTIVE: The aim of this study was to examine whether elevated levels of Lp(a) and OxPL on apolipoprotein B-100-containing lipoproteins (OxPL/apoB) are associated with changes in monocyte subset distribution. METHODS: We included 90 patients with stable coronary artery disease. Lp(a) and OxPL/apoB were measured, and monocyte subsets were identified as classical monocytes (CMs; CD14+ +CD16-), intermediate monocytes (IMs; CD14+ +CD16+), and nonclassical monocytes (NCMs; CD14+CD16+ +) by flow cytometry. RESULTS: In patients with elevated levels of Lp(a) (>50 mg/dL), monocyte subset distribution was skewed toward an increase in the proportion of IM (7.0 +/- 3.8% vs 5.2 +/- 3.0%; P =.026), whereas CM (82.6 +/- 6.5% vs 82.0 +/- 6.8%; P =.73) and NCM (10.5 +/- 5.3 vs 12.8 +/- 6.0; P =.10) were not significantly different. This association was independent of clinical risk factors, choice of statin treatment regime, and inflammatory markers. In addition, OxPL/apoB was higher in patients with elevated Lp(a) and correlated with IM but not CM and NCM. CONCLUSIONS: In conclusion, we provide a potential link between elevated levels of Lp(a) and a proatherogenic distribution of monocyte subtypes in patients with stable atherosclerotic disease. (C) 2015 National Lipid Association. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).
引用
收藏
页码:533 / 541
页数:9
相关论文
共 50 条
  • [1] The Association of Lipoprotein(a) and Circulating Monocyte Subsets with Severe Coronary Atherosclerosis
    Afanasieva, Olga, I
    Filatova, Anastasya Yu
    Arefieva, Tatiana, I
    Klesareva, Elena A.
    Tyurina, Alexandra, V
    Radyukhina, Natalia, V
    Ezhov, Marat, V
    Pokrovsky, Sergei N.
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2021, 8 (06)
  • [2] Elevated lipoprotein (a) levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes mellitus
    Zhang, H-W
    Zhao, X.
    Guo, Y-L
    Gao, Y.
    Zhu, C-G
    Wu, N-Q
    Li, J. J.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2018, 28 (10) : 980 - 986
  • [3] Elevated Levels of Monocyte Activation Markers Are Associated With Subclinical Atherosclerosis in Men With and Those Without HIV Infection
    McKibben, Rebeccah A.
    Margolick, Joseph B.
    Grinspoon, Steven
    Li, Xiuhong
    Palella, Frank J., Jr.
    Kingsley, Lawrence A.
    Witt, Mallory D.
    George, Richard T.
    Jacobson, Lisa P.
    Budoff, Matthew
    Tracy, Russell P.
    Brown, Todd T.
    Post, Wendy S.
    JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (08): : 1219 - 1228
  • [4] Association of Lipoprotein(a) Levels With Myocardial Infarction in Patients With Low-Attenuation Plaque
    Yu, Meng-Meng
    Wang, Ming-Liang
    Wang, Jin-Jin
    Lin, Bo -Li
    Zhao, Xin
    Tao, Xin-Wei
    Chen, Yin-Yin
    Li, Peng-Yang
    Zhang, Jing-Kun
    Ge, Jun -Bo
    Jin, Hang
    Zeng, Meng-Su
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (18) : 1743 - 1755
  • [5] Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease
    Krychtiuk, Konstantin A.
    Kastl, Stefan P.
    Pfaffenberger, Stefan
    Pongratz, Thomas
    Hofbauer, Sebastian L.
    Wonnerth, Anna
    Katsaros, Katharina M.
    Goliasch, Georg
    Gaspar, Ludovit
    Huber, Kurt
    Maurer, Gerald
    Dostal, Elisabeth
    Oravec, Stanislav
    Wojta, Johann
    Speidl, Walter S.
    ATHEROSCLEROSIS, 2014, 237 (02) : 589 - 596
  • [6] Actual situation of lipoprotein apheresis in patients with elevated lipoprotein(a) levels
    Julius, Ulrich
    Tselmin, Sergey
    Schatz, Ulrike
    Fischer, Sabine
    Birkenfeld, Andreas L.
    Bornstein, Stefan R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2019, 40 : 1 - 7
  • [7] High levels of lipoprotein(a) in transgenic mice exacerbate atherosclerosis and promote vulnerable plaque features in a sex-specific manner
    Assini, Julia M.
    Clark, Justin R.
    Youssef, Amer
    Xing, Chuce
    Doerfler, Alexandria M.
    Park, So Hyun
    Saxena, Lavanya
    Yaseen, Adam B.
    Boren, Jan
    Gros, Robert
    Bao, Gang
    Lagor, William R.
    Boffa, Michael B.
    Koschinsky, Marlys L.
    ATHEROSCLEROSIS, 2023, 384
  • [8] Clinical characteristics associated with elevated levels of lipoprotein(a) in patients with vascular risk
    Rubio-Serrano, Javier
    Gullon Ojesto, Alejandra
    Suarez Fernandez, Carmen
    ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO, 2023, 4 (04): : 396 - 401
  • [9] Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease
    Martinovic, I
    Abegunewardene, N
    Seul, M
    Vosseler, M
    Horstick, G
    Buerke, M
    Darius, H
    Lindemann, S
    CIRCULATION JOURNAL, 2005, 69 (12) : 1484 - 1489
  • [10] Plasma lipoprotein(a) levels in patients with slow coronary flow
    Yucel, Habil
    Dogan, Abdullah
    Altinbas, Ahmet
    Akcay, Salaheddin
    Icli, Atilla
    Ceyhan, Betul Mermi
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2013, 9 (04): : 323 - 327